Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Journal of Heart and Lung Transplantation

Volumn 33, Issue 7, 2014, Pages 675-681

  Thomas, Sunu S ^a   Nahumi, Nadav ^a   Han, Jason ^a   Lippel, Matthew ^a   Colombo, Paolo ^a   Yuzefpolskaya, Melana ^a   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Uriel, Nir ^a   Jorde, Ulrich P ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

continuous flow left ventricular assist device; heart failure; mechanical circulatory support; mortality; prognosis; risk score

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONSTRUCT VALIDITY; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; FEMALE; HEART TRANSPLANTATION; HEARTMATE II RISK SCORE; HIGH RISK POPULATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRE OPERATIVE MORTALITY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL MORTALITY; SURVIVAL RATE; AGED; CLINICAL TRIAL; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84904249279     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.02.011     Document Type: Article

References (23)

1. K Lietz, and LW. Miller Patient selection for left-ventricular assist devices Curr Opin Cardiol 24 2009 246 251
2. T Imamura, K Kinugawa, and T Shiga et al. Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device Jpn Circ J 76 2012 1895 1903
3. V Rao, MC Oz, and MA Flannery et al. Revised screening scale to predict survival after insertion of a left ventricular assist device J Thorac Cardiovasc Surg 125 2003 855 862
4. K Lietz, JW Long, and AG Kfoury et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
5. EA Rose, AC Gelijns, and AJ Moskowitz et al. Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
6. JJ Teuteberg, GA Ewald, and RM Adamson et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients J Am Coll Cardiol 60 2012 44 51
7. LW Stevenson, FD Pagani, and JB Young et al. INTERMACS profiles of advanced heart failure: the current picture J Heart Lung Transplant 28 2009 535 541
8. AJ Boyle, DD Ascheim, and MJ Russo et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
9. J Cowger, K Sundareswaran, and JG Rogers et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score J Am Coll Cardiol 61 2013 313 321
10. LW Miller, FD Pagani, and SD Russell et al. Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
11. MS Slaughter, JG Rogers, and CA Milano et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
12. RC Starling, Y Naka, and AJ Boyle et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
13. KD Aaronson, MS Slaughter, and LW Miller et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
14. JK Kirklin, DC Naftel, and RL Kormos et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients J Heart Lung Transplant 32 2013 141 156
15. JC Matthews, FD Pagani, and JW Haft et al. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
16. H Takayama, L Truby, and M Koekort et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era J Heart Lung Transplant 32 2013 106 111
17. A Kilic, I Sultan, and DD Yuh et al. Ventricular assist device implantation in the elderly: nationwide outcomes in the United States J Card Surg 28 2013 183 189
18. TJ George, A Kilic, and CA Beaty et al. Septuagenarians bridged to heart transplantation with a ventricular assist device have outcomes similar to younger patients Ann Thorac Surg 95 2013 1251 1260
19. P Atluri, AB Goldstone, and DM Kobrin et al. Ventricular assist device implant in the elderly is associated with increased, but respectable risk - a multi-institutional study Ann Thorac Surg 96 2013 857 863
20. LW Miller, and M. Guglin Patient selection for ventricular assist devices: a moving target J Am Coll Cardiol 61 2013 1209 1221
21. N Uriel, KA Morrison, and AR Garan et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia Ramp Study J Am Coll Cardiol 60 2012 1764 1775
22. AR Garan, M Yuzefpolskaya, and PC Colombo et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol 61 2013 2542 2550
23. U. Jorde, N. Uriel, and N. Nahumi et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients Circ Heart Fail 7 2014 310 319